Cevimeline Hydrochloride Capsule
Product Images NDC 16571-657

2 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 16571-657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Structural Formula)

Structural Formula (Structural Formula)
Chemical structure of Cevimeline Hydrochloride shown as a molecular diagram including a bicyclic amine structure, an ether linkage, and a methylthioethyl group, with notation indicating the hydrochloride salt and hemihydrate form.*
FDA Label Image

Cevimeline-label (Cevimeline Label)

Cevimeline-label (Cevimeline Label)
Label for Cevimeline Hydrochloride Capsules 30 mg, oral dosage form, by Rising Pharma Holdings, Inc. The label includes the NDC 16571-657-10, states the package contains 100 capsules, and instructs pharmacists to dispense with the patient information leaflet. Storage instructions and dosage directions are partially visible along the right side. A barcode and spot varnish 1 inch by 1.75 inch are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.